Genoskin

Exhibitor

Genoskin is a biotechnology company with research facilities in Toulouse, France, and Salem, MA, USA. Genoskin leverages immunology to mitigate the risk associated with drug, biologics, and vaccine development by providing preliminary access to animal-free, first-in-human data prior to initiating clinical trials.

Genoskin’s ex vivo study platforms contain natural, biostabilized and immunocompetent human skin from representative donor cohorts, which are ideal for evaluating drug efficacy and toxicity for different routes of administration to enable assessment of nonclinical human response to subcutaneous or intradermal administration.

Our experts combine the vast data sets generated by its platforms with advanced analytical technologies, including next-generation transcriptomics, multiplexed proteomics, and AI, to provide actionable study results and reduce the length, costs, and risks of drug development